Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee postal kits for home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

Novosanis research grant

Novosanis is offering a research grant in collaboration with EACR to stimulate innovative research in cancer biomarker detection using urine as a sample type. Urine can be collected in an easy, quick and non-invasive way, and has shown potential to change the way cancer is detected and monitored...

Latest blogpost

Urine as an emerging liquid biopsy for prostate cancer biomarker detection
Current methods for PCa detection lack specificity Prostate cancer (PCa) is the second most frequently diagnosed cancer and a major cause of death in men worldwide. Testing for prostate-specific antigen (PSA) in blood, the current gold standard for PCa screening has limitations. Other non-cancerous...

Upcoming event

There are no events associated with this category.